Novel tetrahydropyran-based peptidomimetics from a bioisosteric transformation of a tripeptide. Evidence of their activity at melanocortin receptors

Bioorg Med Chem. 2003 Jul 17;11(14):3053-63. doi: 10.1016/s0968-0896(03)00274-8.

Abstract

We have prepared novel peptidomimetics based on a 2,4,6-trisubstituted tetrahydropyran. This scaffold was constructed in an isosteric transformation using conceptual constraints imposed on a tripeptide moiety involving O(i)'-C(i+1)(gamma) and O(i)'-N(i+2) formal cyclization modes. A series of regioselective transformations commencing with a substituted dihydropyran-4-one readily provided the required analogues. Specific tetrahydropyrane analogues modeled on PheArgTrp as a truncated version of the melanocortin receptor message sequence, showed activity at the melanocortin receptors MC4R and MC1R. Thus, the 2,4,6-trisubstituted tetrahydropyran scaffold has provided a potentially useful peptidomimetic lead, and conceptual cyclization of peptide moieties can offer a valuable design strategy in peptidomimetic research.

MeSH terms

  • Arginine / chemistry
  • Biomimetic Materials
  • Cells, Cultured
  • Humans
  • Isomerism
  • Models, Chemical
  • Oligopeptides / chemical synthesis
  • Oligopeptides / chemistry*
  • Oligopeptides / pharmacology
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / metabolism
  • Phenylalanine / chemistry
  • Protein Binding
  • Pyrans / chemistry*
  • Pyrans / pharmacology
  • Receptors, Melanocortin / drug effects*
  • Receptors, Melanocortin / genetics
  • Tryptophan / chemistry

Substances

  • Oligopeptides
  • Peptides, Cyclic
  • Pyrans
  • Receptors, Melanocortin
  • Phenylalanine
  • Tryptophan
  • Arginine